Sign in
4

Changes in Ownership

Karyopharm Therapeutics Inc. Filed Acc 0001209191-20-057054

EVP,Chief Reg.&Quality Officer sold 226 shares at $15.58 ($3,521)

  • EVP,Chief Reg.&Quality Officer acquired 765 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Lewis Tanya · EVP,Chief Reg.&Quality Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-10-28 Exercise or conversion : show line 1 in the form +765 765 D
2020-10-30 Sale : show line 2 in the form −226 $15.58 $3,521 539 D
Open-market sales · 226 sh · avg $15.58 · $3,521

Table II: Derivative

1 line
Date Transaction Shares Underlying Owned after D/I
2020-10-28 Exercise or conversion : show line 3 in the form Restricted Stock Units −765 765 2,295 D
Loading xslF345X03/doc4.xml…